INS and Alzheimer disease: In rats, ICV injections of STZ, an established model for AD, impairs spatial and working memory and reduces IR signaling molecules, effects that are normalized by intranasal insulin treatment (Rajasekar et al., 2017; Rostami et al., 2017).